Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Glenda Canderan

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Immunotherapy|July 20, 2010
T helper 17 T cells do good for cancer immunotherapyGlenda Canderan, Paolo Dellabona
Current Opinion in Immunology|December 21, 2013
A systems framework for vaccine designMichael Mooney, Shannon McWeeney, Glenda Canderan, et al.
Current Opinion in HIV and AIDS|October 28, 2010
New approaches to design HIV-1 T-cell vaccinesHélène Perrin, Glenda Canderan, Rafick-Pierre Sékaly, et al.
Current Opinion in Immunology|July 9, 2016
Systems biology and the quest for correlates of protection to guide the development of an HIV vaccineLeticia Kuri-Cervantes, Slim Fourati, Glenda Canderan, et al.
BMC Immunology|August 27, 2021
Innate lymphoid cell dysfunction during long-term suppressive antiretroviral therapy in an African cohortRose Nabatanzi, Lois Bayigga, Stephen Cose, et al.
Clinical Immunology (Orlando, Fla.)|March 1, 2019
Aberrant natural killer (NK) cell activation and dysfunction among ART-treated HIV-infected adults in an African cohortRose Nabatanzi, Lois Bayigga, Stephen Cose, et al.
The Journal of Infectious Diseases|July 20, 2019
Monocyte Dysfunction, Activation, and Inflammation After Long-Term Antiretroviral Therapy in an African CohortRose Nabatanzi, Lois Bayigga, Stephen Cose, et al.
Blood Cancer Journal|July 26, 2023
In-depth cellular and humoral dynamics of the response to COVID-19 vaccine booster in patients with chronic B-cell neoplasmsEmily Ayers, Glenda Canderan, Michael E Williams, et al.
Plos One|August 17, 2010
An efficient strategy to induce and maintain in vitro human T cells specific for autologous non-small cell lung carcinomaGlenda Canderan, Paola Gruarin, Daniela Montagna, et al.
Spora : a Journal of Biomathematics|February 16, 2026
A Probabilistic Modeling Analysis of the Longitudinal Immune Response to Infection and Vaccination Across Demographic Groups and Pulmonary SymptomsJames O'Hanlon, Kaitlyn Sullivan, Lyndsey M Muehling, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Immunotherapy|July 20, 2010
T helper 17 T cells do good for cancer immunotherapyGlenda Canderan, Paolo Dellabona
Current Opinion in Immunology|December 21, 2013
A systems framework for vaccine designMichael Mooney, Shannon McWeeney, Glenda Canderan, et al.
Current Opinion in HIV and AIDS|October 28, 2010
New approaches to design HIV-1 T-cell vaccinesHélène Perrin, Glenda Canderan, Rafick-Pierre Sékaly, et al.
Current Opinion in Immunology|July 9, 2016
Systems biology and the quest for correlates of protection to guide the development of an HIV vaccineLeticia Kuri-Cervantes, Slim Fourati, Glenda Canderan, et al.
BMC Immunology|August 27, 2021
Innate lymphoid cell dysfunction during long-term suppressive antiretroviral therapy in an African cohortRose Nabatanzi, Lois Bayigga, Stephen Cose, et al.
Clinical Immunology (Orlando, Fla.)|March 1, 2019
Aberrant natural killer (NK) cell activation and dysfunction among ART-treated HIV-infected adults in an African cohortRose Nabatanzi, Lois Bayigga, Stephen Cose, et al.
The Journal of Infectious Diseases|July 20, 2019
Monocyte Dysfunction, Activation, and Inflammation After Long-Term Antiretroviral Therapy in an African CohortRose Nabatanzi, Lois Bayigga, Stephen Cose, et al.
Blood Cancer Journal|July 26, 2023
In-depth cellular and humoral dynamics of the response to COVID-19 vaccine booster in patients with chronic B-cell neoplasmsEmily Ayers, Glenda Canderan, Michael E Williams, et al.
Plos One|August 17, 2010
An efficient strategy to induce and maintain in vitro human T cells specific for autologous non-small cell lung carcinomaGlenda Canderan, Paola Gruarin, Daniela Montagna, et al.
Spora : a Journal of Biomathematics|February 16, 2026
A Probabilistic Modeling Analysis of the Longitudinal Immune Response to Infection and Vaccination Across Demographic Groups and Pulmonary SymptomsJames O'Hanlon, Kaitlyn Sullivan, Lyndsey M Muehling, et al.
Pageof 3